Synthesis 2019; 51(18): 3419-3430
DOI: 10.1055/s-0039-1689973
paper
© Georg Thieme Verlag Stuttgart · New York

Copper(II) Acetate Mediated Synthesis of 3-Sulfonyl-2-aryl-2H-chromenes

a   Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung 807, Taiwan, ROC
b   Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan, ROC   Email: mychang@kmu.edu.tw
,
Yu-Hsin Chen
a   Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung 807, Taiwan, ROC
,
Han-Yu Chen
a   Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung 807, Taiwan, ROC
› Author Affiliations
The authors would like to thank the Ministry of Science and Technology of the People’s Republic of China for financial support (MOST 106-2628-M-037-001-MY3).
Further Information

Publication History

Received: 13 April 2019

Accepted after revision: 20 May 2019

Publication Date:
12 June 2019 (online)


Abstract

This paper describes a concise, easy-operation, high-yielding method for the synthesis of 3-sulfonyl-2-aryl-2H-chromenes by a one-pot, straightforward two-step synthetic route, which includes (i) Cu(OAc)2/PyBOP-mediated intermolecular [4+2] annulation of substituted salicylic acids with β-sulfonylstyrenes in the presence of DMAP in refluxing DMF, and (ii) sequential O-alkylation of the resulting sulfonylflavanones with n-butyl bromide. A plausible mechanism is proposed and discussed. This protocol provides a highly effective annulation via one carbon–oxygen (C–O) and one carbon–carbon (C–C) bond formations.

Supporting Information

 
  • References


    • For reviews on the synthesis of chromenes, see:
    • 1a Majumdar N, Paul ND, Mandal S, de Bruin B, Wulff WD. ACS Catal. 2015; 5: 2329
    • 1b Shi Y.-L, Shi M. Org. Biomol. Chem. 2007; 5: 1499
    • 1c Ferreira SB, da Silva FC, Pinto AC, Gonzaga DT. G, Ferreira VF. J. Heterocycl. Chem. 2009; 46: 1080
    • 1d Ellis GP, Lockhart IM. In The Chemistry of Heterocyclic Compounds: Chromenes, Chromanones, and Chromones, Vol. 31. Ellis GP. Wiley-VCH; New York: 2009: 1-196

      Biological activities of 2-aryl-2H-chromenes. For candenatenin E, see:
    • 2a Cheenpracha S, Karalai C, Ponglimanont C, Kanjana-Opas A. J. Nat. Prod. 2009; 72: 1395

    • For hilgartene, see:
    • 2b Gómez-Garibay F, Calderón JS, De La O Arciniega M, Céspedes CL, Téllez-Valdés O, Taboada J. Phytochemistry 1999; 52: 1159

    • For acolbifene, see:
    • 2c Gauthier S, Caron B, Cloutier J, Dory YL, Farve A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, Mérand Y, Bélanger A, Labrie C, Labrie F. J. Med. Chem. 1997; 40: 2117

      For photochromism of 2,2-diaryl-2H-chromenes, see:
    • 3a Queiroz M.-JR. P, Abreu AS, Ferreira PM. T, Oliveira MM, Dubest R, Aubard J, Samat A. Org. Lett. 2005; 7: 4811
    • 3b Moorthy JN, Venkatakrishnan P, Samanta S, Kumar DK. Org. Lett. 2007; 9: 919
    • 3c Berdnikova DV, Paululat T, Jonusauskas G, Peregudova SM, Fedorova OA. Org. Lett. 2017; 19: 5633 ; and references cited therein

      For general syntheses of 2-aryl-2H-chromenes, see:
    • 4a Clark-Lewis JW, Jemison RW. Aust. J. Chem. 1968; 21: 2247
    • 4b Cushman M, Nagarathnam D. J. Med. Chem. 1991; 34: 798

      Organocatalyst-mediated syntheses of 2-aryl-2H-chromenes. For THT, see:
    • 5a Ye L.-W, Sun X.-L, Zhu C.-Y, Tang Y. Org. Lett. 2006; 8: 3853

    • For amines, see:
    • 5b Wang Q, Finn MG. Org. Lett. 2000; 2: 4063

    • For Brønsted acids, see:
    • 5c Moquist PN, Kodama T, Schaus SE. Angew. Chem. Int. Ed. 2010; 49: 7096

    • For BF3·OEt2, see:
    • 5d Doodeman R, Rutjes FP. J. T, Hiemstra H. Tetrahedron Lett. 2000; 41: 5979
    • 5e Gil-Negrete JM, Sestelo JP, Sarandeses LA. Org. Lett. 2016; 18: 4316

      Transition-metal-mediated syntheses of 2-aryl-2H-chromenes. For Co(II), see:
    • 6a Paul ND, Mandal S, Otte M, Cui X, Zhang XP, de Bruin B. J. Am. Chem. Soc. 2014; 136: 1090

    • For Ru(II), see:
    • 6b Hardouin C, Burgaud L, Valleix A, Doris E. Tetrahedron Lett. 2003; 44: 435
    • 6c He H, Ye K.-Y, Wu Q.-F, Dai L.-X, You S.-L. Adv. Synth. Catal. 2012; 354: 1084

    • For Ni(0), see:
    • 6d Graham TJ. A, Doyle AG. Org. Lett. 2012; 14: 1616

    • For Ga(III), see:
    • 6e Yadav JS, Reddy BV. S, Biswas SK, Sengupta S. Tetrahedron Lett. 2009; 50: 5798

    • For Fe(III), see:
    • 6f Calmus L, Corbu A, Cossy J. Adv. Synth. Catal. 2015; 357: 1381

    • For Pd(II), see:
    • 6g Zeng B.-S, Yu X, Siu PW, Scheidt KA. Chem. Sci. 2014; 5: 2277
    • 6h Jiang Z.-Z, Gao A, Li H, Chen D, Ding C.-H, Xu B, Hou X.-L. Chem. Asian J. 2017; 12: 3119
    • 6i Xia Y, Xia Y, Zhang Y, Wang J. Org. Biomol. Chem. 2014; 12: 9333

      For water-mediated syntheses of 2-aryl-2H-chromenes, see:
    • 7a Zhang F.-Z, Tian Y, Li G.-X, Qu J. J. Org. Chem. 2015; 80: 1107
    • 7b Candeias NR, Veiros LF, Afonso CA. M, Gois PM. P. Eur. J. Org. Chem. 2009; 1859

      Synthetic applications of 2-aryl-2H-chromenes. For dimerization, see:
    • 8a Luan Y, Sun H, Schaus SE. Org. Lett. 2011; 13: 6480
    • 8b Devakaram R, Black D, Kumar N. Tetrahedron Lett. 2010; 51: 3636

    • For flavones, see:
    • 8c Banerjee D, Kayal U, Maiti G. Tetrahedron Lett. 2016; 57: 1667

    • For dihydrochalcones, see:
    • 8d Maiti G, Kayal U, Karmakar R, Bhattacharya RN. Tetrahedron Lett. 2012; 53: 6321

    • For cyclopropanations, see:
    • 8e Stokes S, Mustain R, Pickle L, Mead KT. Tetrahedron Lett. 2012; 53: 3890

      Domino oxa-Michael/aldol condensation. For a 3-formyl group, see:
    • 10a Climent MJ, Iborra S, Sabater MJ, Vidal JD. Appl. Catal., A 2014; 481: 27
    • 10b Shen H, Yang K.-F, Shi Z.-H, Jiang J.-X, Lai G.-Q, Xu L.-W. Eur. J. Org. Chem. 2011; 5031

    • For a 3-nitro group, see:
    • 10c Liu S.-X, Jia C.-M, Yao B.-Y, Chen X.-L, Zhang Q. Synthesis 2016; 48: 407
    • 11a Bauer DJ, Selway JW. T, Batchelor JF, Tisdale M, Caldwell IC, Young DA. B. Nature 1981; 292: 369
    • 11b Cheng J.-F, Ishikawa A, Ono Y, Arrhenius T, Zadzan A. Bioorg. Med. Chem. Lett. 2003; 13: 3647
  • 12 CCDC 1811124 (4a), CCDC 1835628 (6b), CCDC 1835629 (6q), CCDC 1835630 (6x), CCDC 1835631 (6y), CCDC 1835632 (6z), CCDC 1835633 (6ab), and CCDC 1842006 (6aj) contain the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.

    • For the complexation of Cu(II) with salicylic acids, see:
    • 13a Chen H.-J, Lin Z.-Y, Li M.-Y, Lian R.-J, Xue Q.-W, Chung J.-L, Chen S.-C, Chen Y.-J. Tetrahedron 2010; 66: 7755
    • 13b Lin CJ, Zheng YQ, Zhang DY, Xu W. Russ. J. Coord. Chem. 2014; 40: 932